Massachusetts voters have rejected a proposal to legalize certain natural psychedelic drugs, marking a setback for the expanding movement to legalize these substances.
The measure would have permitted adults 21 and older to use psychedelics like psilocybin mushrooms at licensed therapy centers, as well as to grow limited amounts at home. A commission would have been responsible for licensing "psychedelic therapy centers," where adults could consume specific psychedelics under the supervision of trained facilitators.
The proposed law outlined the cultivation and regulated sale of five substances: dimethyltryptamine (DMT), mescaline, ibogaine, psilocybin, and psilocyn. The commission would also have determined who could legally administer these drugs, with the first centers would have been expected to open no earlier than 2026.
The initiative followed similar successful measures in Oregon and Colorado, where psilocybin has already been legalized and regulated.
However, opposition from major medical associations highlighted potential risks, particularly for individuals vulnerable to schizophrenia or psychosis, and raised concerns about a possible rise in the black market for home-grown psychedelics.
As of the latest count, with approximately 98.8% of votes tallied, the "No" vote is projected to prevail. Support for "Yes" reached its highest levels in Boston, where 52% of voters were in favor, and in parts of western Massachusetts, including towns like Greenfield and nearby areas.